Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
64.40    1.30 (2.00%)
Bid:
64.40
Ask:
68.20
Spread: 3.80 (5.901%)
Market Cap: £110.71m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Net Asset Value and Dividend Declaration

24 Jul 2025 07:00

RNS Number : 2862S
GCP Asset Backed Income Fund Ltd
24 July 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

FOR IMMEDIATE RELEASE

24 July 2025

GCP Asset Backed Income Fund Limited

(the "Company" or "GCP Asset Backed")

LEI: 213800FBBZCQMP73A815

Net Asset Value and Dividend Declaration

The Company announces that as of 30 June 2025, the unaudited net asset value ("NAV") per ordinary share (including current period revenue) was 79.79 pence per share.

NAV Movement

The NAV per ordinary share decreased by 2.01 pence (2.46%) since the 31 December 2024 audited annual report and accounts. This movement reflects (i) revised estimates of future recoverable amounts, based on updated valuation assumptions and progress in realisation discussions or agreements; and (ii) asset-specific performance impacts, as advised by the Company's independent valuation agent.

Given the commercial sensitivity of ongoing realisation discussions and the increasingly concentrated nature of the portfolio, the Company does not intend to provide further asset-level detail on NAV movements. Further information will be included in the interim accounts for the six-month period ended 30 June 2025, and future disclosures will only be made where such detail would not prejudice the Company's objective of maximising shareholder returns through the orderly realisation of its assets.

Realisations & Capital Allocation

The Company has continued to execute its capital return strategy following the Discontinuation Vote in May 2024, including two compulsory share redemptions and the cancellation of treasury shares, resulting in a 51.22% reduction in share capital to date. Approximately £188.2 million has been returned to shareholders, with 215,606,413 shares remaining in issue as at 30 June 2025.

As at 24 July 2025, the Company and its subsidiaries held a cash balance of approximately £20 million (30 June 2025: £18.4 million), supported by scheduled repayments and further realisations. During the six-month period ended 30 June 2025, the Company received approximately £12 million in loan repayments and other cash realisations. The Board is currently assessing the appropriate level of cash reserves to support the Company's ongoing obligations, including the potential for further capital distributions, the maintenance of the quarterly dividend, and limited potential follow-on investments where necessary to maximise the recovery of existing exposures. Further redemptions remain under consideration, subject to the timing and quantum of future realisations and the Company's liquidity requirements.

The Company's Board of Directors (the "Board") and Gravis Capital Management Ltd, the Investment Manager, continue to progress a pipeline of disposals and remain committed to the orderly realisation of the Company's assets in line with the Realisation Plan published in July 2024 and the update provided as part of the Company's annual report and accounts relating to the period ending 31 December 2024 published on 30 April 2025 and available on the Company's website.

Post-period end, the Company completed the sale of one of its problem loan assets for cash consideration in line with its December 2024 fair value. This asset formed part of the "rump" assets identified in the July 2024 Realisation Plan.

The Company's revised objective remains the orderly realisation of its assets to maximise shareholder returns. Accordingly, the Company will only make new investments where the Board believes doing so will protect, enhance, or accelerate the recovery of an existing investment. As noted in the RNS dated 12 February 2025 a small investment of £0.06 million was made during the period to support an existing development project.

Dividends

The Board is pleased to announce a quarterly dividend in respect of the period from 1 April 2025 to 30 June 2025 of 1.58125 pence per ordinary share (the "Q2 Dividend").

The Company's ordinary shares will go ex-dividend on 31 July 2025 and the Q2 Dividend will be paid on 1 September 2025 to holders of ordinary shares recorded on the register as at close of business on 1 August 2025.

For further information:

GCP Asset Backed Income Fund Limited

Alex Ohlsson, Chairman

+44 (0)15 3482 2251

Gravis Capital Management Limited - Investment Manager

Philip Kent

Luther Ward-Faint

Cameron Gardner

+44 (0)20 3405 8500

Barclays Bank PLC, acting through its Investment Bank - Corporate Broker

Dion Di Miceli

Stuart Muress

James Atkinson

 

+44 (0) 20 7623 2323

BarclaysInvestmentCompanies@barclays.com

Buchanan/Quill - Media Enquiries

Helen Tarbet

Henry Wilson

Nick Croysdill 

+44 (0)20 7466 5000

Notes to the Editor

About GABI

GCP Asset Backed Income Fund Limited is a closed ended investment company. Its shares are traded on the Main Market of the London Stock Exchange. Its investment objective is to undertake a managed wind-down of the Company and realise all existing assets in the Company's portfolio in an orderly manner.

The Company's portfolio comprises a diversified portfolio of predominantly UK based asset backed loans which are secured against contracted, predictable medium to long term cash flows and/or physical assets.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVRJMITMTTTBMA
Date   Source Headline
24th Jul 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
16th Jul 20197:00 amRNSNet Asset Value(s)
1st Jul 20194:04 pmRNSChange of Name Administrator and Company Secretary
28th Jun 20197:00 amRNSTotal Voting Rights
27th Jun 201911:47 amRNSHolding(s) in Company
25th Jun 20198:39 amRNSResult of Placing
13th Jun 20194:14 pmRNSNew Directorship Notification
4th Jun 20199:26 amRNSTotal Voting Rights & Additional Listing
24th May 20197:00 amRNSAdditional Listing
23rd May 20191:39 pmRNSProposed Placing of New Ordinary Shares
23rd May 20191:30 pmRNSResult of AGM & EGM
10th May 20192:06 pmRNSScrip Share Reference Price - Replacement
10th May 201912:17 pmRNSScrip Share Reference Price
1st May 20197:00 amRNSInvestor Report as at 31 March 2019
25th Apr 20194:11 pmRNSHolding(s) in Company
24th Apr 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
16th Apr 20197:00 amRNSRevolving Credit Facility
11th Apr 20197:00 amRNSNet Asset Value(s)
10th Apr 20197:00 amRNSNotices of AGM & EGM
29th Mar 20197:00 amRNSAnnual Report & Financial Statements
29th Mar 20197:00 amRNSTotal Voting Rights
15th Mar 20192:57 pmRNSHolding(s) in Company
1st Mar 20199:55 amRNSTotal Voting Rights and Additional Listing
21st Feb 20197:00 amRNSAdditional Listing
7th Feb 20197:00 amRNSScrip Share Reference Price
31st Jan 20197:00 amRNSInvestor Report as at 31 December 2018
29th Jan 20193:54 pmRNSDirector/PDMR Shareholding
23rd Jan 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
23rd Jan 20197:00 amRNSPossible Equity Raise
17th Jan 20194:54 pmRNSHolding(s) in Company
17th Jan 20197:00 amRNSNet Asset Value(s)
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 20187:00 amRNSConversion of C Shares
11th Dec 20187:00 amRNSResult of Placing
5th Dec 20187:00 amRNSProposed Placing of Ordinary Shares
30th Nov 20189:25 amRNSTotal Voting Rights & Additional Listing
28th Nov 20187:00 amRNSConversion of C Shares
21st Nov 20187:00 amRNSAdditional Listing
8th Nov 20187:00 amRNSScrip Share Reference Price
1st Nov 20187:00 amRNSInvestor Report as at 30 September 2018
31st Oct 20187:00 amRNSTotal Voting Rights
23rd Oct 20187:00 amRNSDividend Declaration & Scrip Dividend Alternative
15th Oct 20187:00 amRNSNet Asset Value(s)
10th Oct 20182:42 pmRNSTotal Voting Rights
2nd Oct 20183:50 pmRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSResult of OO, Placing and OFS
28th Sep 20187:00 amRNSTotal Voting Rights
7th Sep 20181:13 pmRNSC Share Issue and publication of prospectus
5th Sep 20187:00 amRNSHalf-year Report & Financial Statements
3rd Sep 20189:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.